Tenderwize
Retour à la recherche

Pharmaceutical Contracts with Accession Option

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2028 · 611 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarder
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

50/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

40 / 100

Facteurs de risque

Missing estimated value and award criteria make it difficult to assess tender's attractiveness and fairness.

The notice states it is not a public procurement, which may affect legal recourse and obligations.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2028
  • Supply of pharmaceutical products (active substance: Estriol) and combinations as per procurement documents.
  • Framework agreement with accession option for additional parties.
Afficher le résumé complet

This is a framework agreement with an accession option for pharmaceutical products (active substance: Estriol) issued by BARMER Beschaffung und Vergabe in Germany. The procedure is formally labeled as an open procedure, but the notice explicitly states that it is not a public procurement subject to EU directives. The tender covers a single lot and is conducted electronically. The deadline for submission is 1 May 2028. No estimated value or award criteria are provided in the notice.

Risques

Missing estimated value and award criteria make it difficult to assess tender's attractiveness and fairness.

The notice states it is not a public procurement, which may affect legal recourse and obligations.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Electronic submission via Ouvrir le portail
  • Submission deadline: 1 May 2028, 10:00 UTC.
  • Language of procedure: German.

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Wuppertal, DEU

Identifiant

992-80322-57

Activité

Health

Lots (1)

LOT-0000

Pharmaceutical Contracts with Accession Option

Framework agreement covering various active substances (details in procurement documents). Includes a one-time extension option of 3 months until 30 September 2028. Place of performance is Wuppertal, Germany.

SuppliesFrameworkEU fundedElectronic submission

Localisation

Wuppertal, Germany

Durée

Jul 2026 - Sep 2028

Catégorie

Pharmaceutical products

Date limite

Deadline May 01, 2028

Détails de la procédure

Date de publication
28 Jun 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
442094-2026

Documents (1)

Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30